Ascendis Pharma A/S - COMMON STOCK (ASND)

CUSIP: 04351P101

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
58,365,166
Total 13F shares
63,751,521
Share change
+1,019,407
Total reported value
$8,776,308,689
Put/Call ratio
272%
Price per share
$137.67
Number of holders
212
Value change
+$115,863,512
Number of buys
113
Number of sells
103

Quarterly Holders Quick Answers

What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ASND - Ascendis Pharma A/S - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
17%
9,710,428
$1,449,864,005 30 Sep 2024
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
8.8%
5,133,766
$766,522,642 30 Sep 2024
13F
Avoro Capital Advisors LLC
13F
Company
8.5%
4,988,888
$744,890,867 30 Sep 2024
13F
FMR LLC
13F
Company
8.4%
4,907,846
$732,790,486 30 Sep 2024
13F
Artisan Partners Limited Partnership
13F
Company
7.6%
4,411,111
$658,622,983 30 Sep 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
7.2%
4,186,694
$625,074,910 30 Sep 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
3.6%
2,121,128
$316,706,000 30 Sep 2024
13F
Capital International Investors
13F
Company
3.6%
2,109,390
$314,953,021 30 Sep 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
3.2%
1,866,986
$278,759,680 30 Sep 2024
13F
T. Rowe Price Investment Management, Inc.
13F
Company
3%
1,765,042
$263,539,000 30 Sep 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
2.2%
1,261,480
$188,351,579 30 Sep 2024
13F
FRANKLIN RESOURCES INC
13F
Company
2.5%
1,459,723
$187,516,016 30 Sep 2024
13F
Invesco Ltd.
13F
Company
2%
1,162,245
$173,534,800 30 Sep 2024
13F
Camber Capital Management LP
13F
Company
1.2%
700,000
$104,517,000 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
1.1%
669,717
$99,995,894 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
1.1%
663,924
$99,130,492 30 Sep 2024
13F
Spyglass Capital Management LLC
13F
Company
1.1%
652,841
$97,475,690 30 Sep 2024
13F
FIL Ltd
13F
Company
1.1%
640,259
$95,597,071 30 Sep 2024
13F
BlackRock, Inc.
13F
Company
0.92%
536,104
$80,045,688 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.86%
501,690
$74,907,334 30 Sep 2024
13F
TimesSquare Capital Management, LLC
13F
Company
0.86%
500,920
$74,792,365 30 Sep 2024
13F
Point72 Asset Management, L.P.
13F
Company
0.85%
495,547
$73,990,123 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.84%
490,351
$73,214,308 30 Sep 2024
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.83%
486,957
$72,707,550 30 Sep 2024
13F
BROWN ADVISORY INC
13F
Company
0.8%
467,652
$69,825,120 30 Sep 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.78%
454,788
$67,904,396 30 Sep 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.68%
397,013
$59,278,011 30 Sep 2024
13F
Siren, L.L.C.
13F
Individual
0.6%
347,921
$51,948,085 30 Sep 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.59%
346,746
$51,772,712 30 Sep 2024
13F
Rock Springs Capital Management LP
13F
Company
0.56%
325,000
$48,525,750 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
0.54%
312,488
$46,657,735 30 Sep 2024
13F
S.c.a. Candriam
13F
Individual
0.48%
282,331
$42,152,953 30 Sep 2024
13F
SEI INVESTMENTS CO
13F
Company
0.47%
273,747
$40,873,134 30 Sep 2024
13F
Duquesne Family Office LLC
13F
Company
0.45%
265,040
$39,573,000 30 Sep 2024
13F
ARS Investment Partners, LLC
13F
Company
0.45%
263,111
$39,285,103 30 Sep 2024
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.44%
258,210
$38,553,335 30 Sep 2024
13F
Vestal Point Capital, LP
13F
Company
0.43%
250,000
$37,327,500 30 Sep 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.43%
253,124
$36,606,793 30 Sep 2024
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.42%
243,856
$36,410,000 30 Sep 2024
13F
Woodline Partners LP
13F
Company
0.4%
235,018
$35,090,538 30 Sep 2024
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.39%
228,525
$34,121,067 30 Sep 2024
13F
Polar Capital Holdings Plc
13F
Company
0.39%
225,000
$33,594,750 30 Sep 2024
13F
MARSHALL WACE, LLP
13F
Company
0.38%
221,075
$33,008,709 30 Sep 2024
13F
Q Global Advisors, LLC
13F
Company
0.38%
219,459
$32,767,000 30 Sep 2024
13F
Saturn V Capital Management LP
13F
Company
0.34%
200,285
$29,904,553 30 Sep 2024
13F
Finepoint Capital LP
13F
Company
0.33%
190,072
$28,379,650 30 Sep 2024
13F
LOOMIS SAYLES & CO L P
13F
Company
0.32%
184,623
$27,566,000 30 Sep 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.31%
179,318
$26,773,971 30 Sep 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.31%
178,705
$26,682,444 30 Sep 2024
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.28%
161,410
$24,100,187 30 Sep 2024
13F

Institutional Holders of Ascendis Pharma A/S - COMMON STOCK (ASND) as of Q4 2024

As of 31 Dec 2024, Ascendis Pharma A/S - COMMON STOCK (ASND) was held by 212 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 63,751,521 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, FMR LLC, Artisan Partners Limited Partnership, JANUS HENDERSON GROUP PLC, Capital International Investors, T. Rowe Price Investment Management, Inc., PRICE T ROWE ASSOCIATES INC /MD/, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/. This page lists 214 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
218
Q4 2024 holders
212
Holder diff
-6
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .